Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mitomycin C during Nephroureterectomy for UTUC
NCT03658304Phase 2Completed
- Sponsor
- University of Florida
- Start
- Dec 2018
- Primary completion
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of mitomycin c in upper urinary tract urothelial carcinoma (UTUC), sponsored by University of Florida. Primary endpoint: Bladder Tumor Recurrence Rate at 1 year. Started Dec 2018; status: completed.
02
Drugs
mitomycin c
03
Conditions
upper urinary tract urothelial carcinoma (UTUC)
Beyond the preview
Go deeper on NCT03658304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03658304.